Resource Library

Clindata International, a South Africa-based CRO specializing in Animal Health clinical trials, has used Medrio EDC since 2013.

Swing Therapeutics leveraged Medrio ePRO in a proof-of-concept for a decentralized hybrid study. Electronic Patient-Reported Outcomes (ePRO) technology was used to assess the results of varying digital therapies and the...

Paragonix Technologies selected Medrio EDC for their GUARDIAN-HEART clinical study. Electronic Data Capture (EDC) technology is being used to collect and manage registry data, examining the effect of controlled hypothermic...

TargetCancer Foundation implemented Medrio’s remote consent function in their TCF-001 TRACK study, which has an objective to determine if rare tumors can benefit from matched molecular therapy. The study is...

Now, more than ever, sponsors and CROs need to prioritize including patient engagement in their study builds from the ground-up. This involves defining processes to remove barriers for access, increasing awareness and education for clinical trials, and creating effective exchanges between patients and their clinicians.

When your trials rely on an investigational product (IP), your study timeline, budget, and overall success are closely tied to having the right product available at the right time and site. Once randomization is added in, sponsors can struggle to maintain an increasingly complex supply chain. Achieve operational efficiency with RTSM.